Nucleic acids and corresponding proteins entitled 282P1G3...

Details Nucleic acids and corresponding proteins entitled 282P1G3... Nucleic acids and corresponding proteins entitled 282P1G3...

2006-05-23

2009-11-03

Yaen, Christopher H. (Department: 1643)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C424S184100

Reexamination Certificate

active

07612172

ABSTRACT:
A novel gene 282P1G3 and its encoded protein, and variants thereof, are described wherein 282P1G3 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 282P1G3 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 282P1G3 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 282P1G3 can be used in active or passive immunization.

REFERENCES:
patent: 6476212 (2002-11-01), Lalgudi et al.
patent: 6576607 (2003-06-01), Schachner
patent: 6682888 (2004-01-01), Loring et al.
patent: 2004/0022790 (2004-02-01), Schachner
patent: 20103510 (2001-06-01), None
patent: 1 394 274 (2004-03-01), None
patent: 1 447 413 (2004-08-01), None
patent: WO-93/16178 (1993-08-01), None
patent: WO-96/32959 (1996-10-01), None
patent: WO-98/45435 (1998-10-01), None
patent: WO-00/58357 (2000-10-01), None
patent: WO-01/55206 (2001-08-01), None
patent: WO-01/55314 (2001-08-01), None
patent: WO-01/57272 (2001-08-01), None
patent: WO-01/57273 (2001-08-01), None
patent: WO-01/57274 (2001-08-01), None
patent: WO-01/57275 (2001-08-01), None
patent: WO-01/57276 (2001-08-01), None
patent: WO-01/57277 (2001-08-01), None
patent: WO-01/57278 (2001-08-01), None
patent: WO-01/66719 (2001-09-01), None
patent: WO-01/75067 (2001-10-01), None
patent: WO-01/86003 (2001-11-01), None
patent: WO-01/92581 (2001-12-01), None
patent: WO-02/10449 (2002-02-01), None
patent: WO-02/18632 (2002-03-01), None
patent: WO-03/016475 (2003-02-01), None
patent: WO-03/068268 (2003-08-01), None
patent: WO-03/080795 (2003-10-01), None
patent: WO-03/087768 (2003-10-01), None
patent: WO-2004/016734 (2004-02-01), None
patent: WO-2004/023973 (2004-03-01), None
patent: WO-2004/028479 (2004-04-01), None
patent: WO-2004/048938 (2004-06-01), None
patent: WO-2004/066948 (2004-08-01), None
Greenbaum et al., Genome Biology, 2003, vol. 4(9), pp. 117.1-117.8.
Alberts et al. Molecular Biology of the Cell, 3rd Edition, 1994, p. 465.
Mallampalli et al., Biochem. J. 1996, vol. 38, pp. 333-341.
Fu et al., EMBO journal, 1996, vol. 15, pp. 4392-4401.
Alberts et al., Molecular Biology of the Cell, 3rded., (1994) p. 465.
Database GenBank, Accession No. ABG21359, gene sequence, WO2001/175067, SEQ ID No. 51718.
Fu et al., EMBO Journal (1996) 15:4392-4402.
Greenbaum et al., Genome Biology (2003) 4(9):117.1-117.8.
International Search Report for PCT/US03/14921.
Mallampalli et al., Biochem. J. (1996) 38:333-341.
International Preliminary Examination Report for PCT/US03/14921, mailed on Dec. 12, 2006, 7 pages.
Byers et al., International Journal of Experimental Pathology (2000) 81(6):391-404.
Database Geneseq, accession no. ABA07431 (2002).
Database Geneseq, accession no. ABA07432 (2002).
Database Geneseq, accession no. ABA07435 (2002).
Database Refseq, accession no. NM 006614 (2002).
Diatchenko et al., PNAS USA (1996) 93(1):6025-6030.
Iacobuzio-Donahue et al., The American Journal of Pathology Apr. (2002) 160(4):1239-1249.
Nakatsura et al., Biochemical and Biophysical Research Communications (2001) 281(4):936-944.
Supplementary Partial European Search Report for EP 03788229.7, mailed Jul. 11, 2007, 8 pages.
Von Stein et al., Nucleic Acids Research (1997) 25(13):2598-2602.
Restriction Requirement for U.S. Appl. No. 10/435,751, mailed Nov. 2, 2005.
Response to Restriction Requirement for U.S. Appl. No. 10/435,751, filed Nov. 30, 2005.
Non-Final Office Action for U.S. Appl. No. 10/435,751, mailed Jan. 12, 2006.
Response to Non-Final Office Action for 10/435,751, filed Jan. 26, 2006.
Final Office Action for U.S. Appl. No. 10/435,751, mailed Feb. 21, 2006.
Response to Final Office Action for U.S. Appl. No. 10/435,751, filed Mar. 8, 2006.
Interview Summary for U.S. Appl. No. 10/435,751, mailed Mar. 23, 2006.
Notice of Allowance for U.S. Appl. No. 10/435,751, mailed Apr. 5, 2006.
Interview Summary for U.S. Appl. No. 10/435,751, mailed May 3, 2006.

Affiliated with

Also associated with

Rating

Nucleic acids and corresponding proteins entitled 282P1G3... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acids and corresponding proteins entitled 282P1G3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids and corresponding proteins entitled 282P1G3... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4095242